Precision for Medicine

Overview

Precision for Medicine is a company operating within the business services sector, specifically focused on research and development in the biotechnology and pharmaceuticals industries. Founded in 2012 and based in the United States, the company employs between 1,001 and 5,000 individuals and reported revenue of approximately $528 million. Precision for Medicine specializes in providing comprehensive solutions for the biotech sector, including the validation of assays and methodologies for measuring immune responses in various therapeutic contexts. One of their published case studies discusses the validation of an IFN-γ ELISpot assay, which is utilized to assess T-cell responses against viral antigens in the context of AAV-based gene therapy. This indicates the company's involvement in advanced therapeutic development and its commitment to ensuring the reliability of immunological assays in clinical applications. The limited published content suggests a focus on case studies that highlight their expertise in assay validation and immune response measurement, which are critical components in the development of gene therapies.

Industry